Naltrexone Treatment Centers in Oregon

Yes. Providers in Oregon must document a current OUD diagnosis to prescribe naltrexone as part of medication-assisted treatment. The intake assessment typically takes 60–90 minutes and includes a physical exam, drug screen, and psychiatric history — results are used to confirm eligibility.

Many Oregon community behavioral-health agencies and federally qualified health centers offer sliding-scale fees based on household income. Sliding-scale fees commonly bring a weekly methadone visit down to $5–$25. Ask naltrexone providers in your area about discounted rates when you call.

Yes. Oregon Health Plan (OHP) covers the medication (methadone, buprenorphine, or naltrexone), counseling sessions, group therapy, drug screening, and care coordination as an integrated MAT benefit. Peer-recovery support is also reimbursable in Oregon under the state plan.

Yes. Parity law requires equal coverage for the medication and counseling components of MAT. Counseling copays often match mental-health visit copays (typically $20–$50 for commercial plans in Oregon). Providers bill counseling and medication separately.

Oregon’s Good Samaritan law provides immunity from low-level drug-possession prosecution when someone seeks help for an overdose. MAT enrollment is not penalized; Oregon specifically prohibits probation or family court from forcing patients to stop naltrexone.

Tapering happens under medical supervision over weeks to months — usually slower for methadone, faster for buprenorphine. Your Oregon provider will monitor withdrawal symptoms and cravings, and resume MAT immediately if cravings return. Never taper without clinical oversight.

Yes. Buprenorphine induction and follow-up are routinely delivered by telehealth in Oregon under permanent federal rules. Naltrexone can be prescribed via telehealth too. Methadone induction requires an in-person OTP visit for the first dose.

Feeling worse shortly after the first buprenorphine dose can indicate precipitated withdrawal (taken too soon after a full agonist). Call your Oregon clinic immediately — the team can adjust timing, switch to micro-induction, or provide supportive medication to relieve symptoms.

Buprenorphine and methadone do not test positive on standard 5-panel drug tests — specialty panels are needed. Naltrexone and its metabolites are not screened on standard panels. Share an MAT provider letter with any employer or court drug-testing program to avoid confusion.

No — abrupt discontinuation is dangerous for the pregnancy. Call your Oregon MAT clinic right away; the team will coordinate with obstetrics to continue medication safely and arrange any dose adjustments needed as the pregnancy progresses.

Yes. Family counseling is a standard component of many Oregon MAT programs; sessions with a partner, parent, or adult child can be scheduled with the patient’s consent. Al-Anon and Nar-Anon groups provide parallel support for family members.

Yes. Your records are protected by federal law 42 CFR Part 2, which is stricter than HIPAA. Disclosure requires your signed consent or a specific court order; even law enforcement cannot access records without one of these.